Benchmark developing cat allergy vaccine
Benchmark Animal Health, the UK business that has largely specialized in aquaculture vaccines, is working with a Swiss research company to develop a vaccine to neutralize the Fel d 1 protein that is the primary cause of human allergic reactions to cats.